Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28990063
Publication Date : //

Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma.


Gene expression data were analyzed in order to identify critical genes in breast invasive carcinoma (BRCA). Data from 1,073 BRCA samples and 99 normal samples were analyzed, which were obtained from The Cancer Genome Atlas. Differentially expressed genes (DEGs) were identified using the significance analysis of microarrays method and a functional enrichment analysis was performed using the Database for Annotation, Visualization and Integrated Discovery. Relevant microRNAs (miRNAs), transcription factors (TFs) and associated small molecule drugs were revealed by Fisher's exact test. Furthermore, protein‑protein interaction (PPI) information was downloaded from the Human Protein Reference Database. Interactions with a Pearson's correlation coefficient >0.5 were identified and PPI networks were subsequently constructed. A survival analysis was also conducted according to the Kaplan‑Meier method. Initially, the 1,073 BRCA samples were clustered into seven groups, and 5,394 DEGs that were identified in ≥4 groups were selected. These DEGs were involved in the cell cycle, ubiquitin‑mediated proteolysis, oxidative phosphorylation and human immunodeficiency virus infection. In addition, TFs, including Sp1 transcription factor, DAN domain BMP antagonist family member 5, MYCN proto‑oncogene, bHLH transcription factor and cAMP responsive element binding protein (CREB)1, were identified in the BRCA groups. Seven PPI networks were subsequently constructed and the top 10 hub genes were acquired, including RB transcriptional corepressor 1, inhibitor of nuclear factor (NF)‑κB kinase subunit γ, NF‑κB subunit 2, transporter 1, ATP binding cassette subfamily B member, CREB binding protein and proteasome subunit α3. A significant difference in survival was observed between the two combined groups (groups‑2, ‑4 and ‑5 vs. groups‑1, ‑3, ‑6 and ‑7). In conclusion, numerous critical genes were detected in BRCA, and relevant miRNAs, TFs and small molecule drugs were identified. These findings may advance understanding regarding the pathogenesis of BRCA.

Authors : Li Yi , Wang Yongsheng ,

Related products :

Catalog number Product name Quantity
XGC-BiRDS-ChipSeq12 Bioinformatics analysis of ChipSeq data for identification of binding sites for DNA-associated proteins Upto 12 samples
BBS-ADV1 Biostatistics and Bioinformatics Advanced Analytic Service for 2 groups and more than 25 samples per group. Service includes Data Cluster Analysis, Data Classification Analysis and Assay Performance A 25 samples or more
XGC-BiRDS-MeDIP-Seq Bioinformatics analysis of Methylome data for Methylation analysis Sample
XGC-BiRDS-WGBS Bioinformatics analysis of Whole Genome Bisulphite Sequencing data for Methylation analysis Sample
BR1921 High_density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases_192 cores
XGC-BiRDS-NextSeq-sRNA-Ref Bioinformatics analysis of NextSeq 500 data: Comprehensive Small RNA Expression profiling Sample
XGC-BiRDS-MiSeq-sRNA-Ref Bioinformatics analysis of MiSeq data: Comprehensive Small RNA Expression profiling Sample
XGC-BiRDS-HiSeq-sRNA-Ref Bioinformatics analysis of HiSeq 2000 data: Comprehensive Small RNA Expression profiling Sample
BR1921 High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases_192 cores; ihc Anti-Actin confirmed
XGC-BiRDS-HiSeq-GBSdata48 Bioinformatics analysis of GBS data for preparation of genetic per association map Dataset of 48 samples having upto 3 million SE/PE reads per sample
XGC-BiRDS-MitoSeq-Denovo Bioinformatics of data for comprehensive mitochondria genome analysis Sample
XGC-BiRDS-HiSeq-GBSdata96 Bioinformatics analysis of GBS data for preparation of genetic per association map Dataset of 96 samples having upto 1 million SE/PE reads per sample
XGC-BiRDS-NextSeq-MetaSeq Bioinformatics analysis of NextSeq500 data for comprehensive Metagenomics Sample
XGC-BiRDS- HumanWGS Bioinformatics of data for comprehensive Human reference based genome Analysis Sample
XGC-BiRDS-NextSeq-Exomedata16 Bioinformatics analysis of NextSeq500 data for comprehensive Exome study Dataset upto 16 samples
XGC-BiRDS-eQTL Bioinformatics analysis of eQTL data for assembly, for eQTL mapping and SNP data 4 datasets
XGC-BiRDS-WGS-Hyb-Asmbl1 Bioinformatics of Roche and MiSeq data using hybrid approach for denovo genome analysis Sample
XGC-BiRDS-WGS-Hyb-Asmbl3 Bioinformatics of MiSeq and NextSeq 500 data using Hybrid approach for Denovo genome analysis Sample
XGC-BiRDS-WGS-Hyb-Asmbl2 Bioinformatics of Roche, MiSeq and NextSeq 500 data using Hybrid approach for Denovo genome analysis Sample
XGC-BiRDS-MiSeq-sRNA-nonRef Bioinformatics analysis of NextSeq 500 data: Comprehensive Small RNA Discovery and profiling Sample
XGC-BiRDS-WGS-Hyb-Asmbl5 Bioinformatics of MiSeq and NextSeq 500 per HiSeq 2000 data using Hybrid approach for Denovo genome analysis Sample
XGC-BiRDS-WGS-Hyb-Asmbl6 Bioinformatics of MiSeq, NextSeq 500 per HiSeq 2000 and PacBio data using Hybrid approach for Denovo genome analysis Sample
XGC-BiRDS-WGS-Hyb-Asmbl4 Bioinformatics of Roche, MiSeq and NextSeq 500 per HiSeq 2000 data using Hybrid approach for Denovo genome analysis Sample
XGC-BiRDS-WGS-Hyb-Asmbl7 Bioinformatics of Roche, MiSeq, NextSeq 500 per HiSeq 2000 and Pacbio data using Hybrid approach for Denovo genome analysis Sample
BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases_80cores, replacing BR802


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur